CClinicalTrials.gg
RecruitingNCT06011278Updated Sep 5, 2023

The Effect of Community-Provided Psychosocial Support Videos on Disease Attitudes and Symptoms

An interventional study of Community Supported Videos in Cancer, sponsored by Koç University. Recruiting at 1 site in Turkey. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-09-05.

Sponsored by Koç University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years 1 month ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled Feb 2023, registered Aug 2023).
  • Started Feb 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
All
01

Study summary

The effects of psychosocial support on the disease process have been studied with many different groups and diseases, and even the psychosocial support needed by the family of the child with a chronic disease has been the subject of research, but studies focusing directly on the needs of the child have been very limited. Although it is seen in the existing literature that studies such as art and play therapy or educational programs have been carried out to improve the attitudes of pediatric oncology patients towards their own diseases, no study has been found that investigated the effects of social/social support in pediatric oncology patients. In order to contribute to this limitation in the literature, this study aimed to examine the effects of community-provided psychosocial support videos on the attitudes and symptoms of pediatric oncology patients.

Read the detailed description

Cancer can affect every individual regardless of age and gender, causing individuals to experience a situation they were not used to before. People may not be able to apply the coping mechanisms they know or they may not find enough coping strength in themselves. This situation can cause individuals to experience emotions such as fear, anxiety and stress. At the beginning of the periods when the diagnosis of cancer is particularly difficult to cope with, comes the period of adolescence and adolescence, which covers the age range of 10-18, in which we plan to conduct the research.

During this period, relationships with people other than parents gained importance; the interest is on peers and non-peer social relationships; It is a developmental period in which there are sudden fluctuations in emotions, especially due to physical changes, and in which he is more inclined to isolate himself from the social environment. They need external approval and encouragement in the changes that occur with their physical and mental developments. Even in healthy children, the lack of this approval and social support may result in a negative development; Pediatric oncology patients are more vulnerable due to the side effects of the disease and treatment process or the physical and psychological effects it causes. For children whose psychosocial development continues, being diagnosed with cancer causes an additional difficulty in their developmental processes. Because children have less or inadequate coping mechanisms than the average adult during this period; This may make it difficult to accept the disease due to the negative effects of diagnosis and treatment.

This period, which is considered more vulnerable to trauma, makes the situation more complicated and tiring for a pediatric oncology patient compared to an adult cancer patient. For this reason, it is very important to control and manage the attitudes of patients towards their own diseases. Minimizing psychosocial problems in order to get the best benefit from the treatment process will also increase the patient's efficiency from the treatment. In this study, it is aimed to evaluate the effect of the psychosocial support videos provided by the community to pediatric oncology patients aged 10-18 on the children's attitudes towards their own disease and treatment-related symptoms.

02

Conditions studied

  • Cancer
03

In context

Lead sponsor

Koç University is the lead sponsor of 106 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • In the 10-18 age group,
  • Newly diagnosed with cancer (maximum three months ago),
  • Ongoing active treatment,
  • Speaking in Turkish,
  • Having no visual, auditory, and mental problems,
  • Knowing the diagnosis,
  • Children who volunteer to participate in the research and their parents will be included.

Exclusion criteria

Exclusion Criteria:

  • The hospitalization period is less than 4 weeks,
  • Neutropenic children,
  • In the terminal period,
  • With intense pain expression,
  • Being under any sedative/anticonvulsant/analgesic effect,
  • Children and their parents who apply to the hospital with a life-threatening illness/condition will not be included.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Community-supported videos

    Community-supported videos will be sent to the children in the experimental group once a week for a month. At the end of four weeks, the "Chıld Attıtude Toward Illness Scale" and the "Memorial Symptom Assessment Scale" will be administered to the children again.

    Other: Community Supported Videos

  • No intervention
    Standard care

    Children in the control group will receive the standard care of the pediatric oncology clinic.At the end of four weeks, the "Chıld Attıtude Toward Illness Scale" and the "Memorial Symptom Assessment Scale" will be administered to the children again.

Interventions

  • OtherCommunity Supported Videos

    Volunteers will be asked to create a maximum of three minutes of content that will psychosocially strengthen and motivate pediatric oncology patients. In the videos, information will be given about not using words such as cancer/oncology/tumor and not including private and personal information. Videos will be created in such a way that they can be edited, merged or deleted accordingly. The applications of volunteer individuals will be made through social media (Instagram), the collection of these videos will be followed in accordance with the voluntary consent forms, and the volunteers will be informed in detail about the use of visual and verbal data. Children will be sent videos featuring different volunteers each week. The content of the videos will be controlled by the child clinical psychologist and researchers. Inappropriate videos will not be included in the research.

06

What researchers measure

Primary outcomes

  1. Chıld Attıtude Toward Illness Scale

    It was developed to measure the attitudes of children with chronic diseases towards their own diseases. During the evaluation, the scores obtained from 13 items are added and divided into 13 or according to the number of items.The total score range is 1 to 5. A score of 1 and 2 indicates negative attitude, 3 indicates neutral attitude, and 4 and 5 indicates positive attitude.

    Time frame: Three week

Secondary outcomes

  1. Memorial Symptom Assessment Scale

    The Memorial Symptom Assessment Scale is developed to determine the symptoms experienced in the last week of children aged 10-18 years who are followed up with the diagnosis of cancer. your scale; It has three sub-dimensions: physical, psychological and general condition index. The Turkish validity and reliability of the scale was done by Atay et al.The lowest score is 30 and the highest score is 120. A high score indicates that the symptom is high in frequency, severity, and distress for the child.

    Time frame: Three week

07

Study locations

1 of 1 sites recruiting
  • Koc University
    Istanbul, Zeytinburnu, Turkey
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06011278
Lead sponsor
Koç University
Responsible party
Eysan Hanzade Umac (Teaching Assisstant, Koç University) — Principal investigator
First posted
Aug 25, 2023
Start date
Feb 1, 2023
Primary completion
Sep 8, 2023 (estimated)
Completion
Sep 11, 2023 (estimated)
Last update
Sep 5, 2023

Study contacts

Eyşan Hanzade Umaç
Contact
eumac14@ku.edu.tr
5068418841 ext. +9
Remziye Semerci, Assit.Prof.
Contact
rsemerci@ku.edu.tr
0 (535) 011 28 21
Eyşan Umaç, MsC
study chair · Koç University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion